This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lemström, K. B. Articles by Koskinen, P. K. Search for Related Content PubMed PubMed Citation Articles by Lemström, K. B. Articles by Koskinen, P. K. Pubmed/NCBI databases Substance via MeSH

(Circulation. 1997;96:1240-1249.)
© 1997 American Heart Association, Inc.

Articles

Expression and Localization of Platelet-Derived Growth Factor Ligand and Receptor Protein During Acute and Chronic Rejection of Rat Cardiac Allografts

Karl B. Lemström, MD, PhD; ; Petri K. Koskinen, MD, PhD

From the Transplantation Laboratory, University of Helsinki, and Helsinki University Central Hospital, Finland.

Correspondence to Dr Karl Lemström, Transplantation Laboratory, PO Box 21 (Haartmaninkatu 3), FIN-00014 University of Helsinki, Finland. E-mail Karl.Lemstrom{at}Helsinki.Fi

Background The molecular mechanisms of cardiac allograft vasculopathy (CAV) remain largely unknown. Using rat cardiac allografts, we examined by immunohistochemistry the expression and localization of platelet-derived growth factor ligand (PDGF-AA and -BB) and receptor (R and Rß) proteins during acute and chronic rejection.

Methods and Results In acute rejection, a prominent induction of both PDGF ligand and receptor proteins occurred in the interstitial mononuclear inflammatory cells (P<.05), most of which were ED1-immunoreactive. PDGF-Rß was also induced in the capillary endothelium (P<.01). In cardiac allografts with severe intimal thickening, PDGF-AA expression was localized to the media and intima, whereas PDGF-BB expression was less prominent and was detected mainly in interstitial ED1-immunoreactive inflammatory cells. Double staining revealed that intimal cells expressing PDGF-AA were -smooth muscle actin–positive but also -smooth muscle actin–negative myofibroblast-like cells and to a lesser extent, ED1-immunoreactive cells. Both PDGF-R and -Rß expression occurred in intimal, arterial endothelial, and interstitial mononuclear inflammatory cells. High-dose cyclosporin A (CsA) treatment significantly reduced both PDGF-AA and PDGF-R expression in intimal cells. Furthermore, linear regression analysis revealed that PDGF-AA, PDGF-R, and PDGF-Rß expression in intimal cells and PDGF-BB expression in interstitial mononuclear inflammatory cells correlated with intimal thickening.

Conclusions Alloimmune injury induces the expression of PDGF ligands, especially of PDGF-AA, in the graft vasculature and sufficient immunosuppression with CsA suppresses the expression of PDGF and inhibits the development of CAV. PDGF may have a substantial role in the regulation of smooth muscle cell migration and proliferation in an autocrine or paracrine manner during the development of CAV.

Key Words: transplantation • immunohistochemistry • arteriosclerosis

This article has been cited by other articles:

				J. Dumortier, D. N. Streblow, A. V. Moses, J. M. Jacobs, C. N. Kreklywich, D. Camp, R. D. Smith, S. L. Orloff, and J. A. Nelson Human Cytomegalovirus Secretome Contains Factors That Induce Angiogenesis and Wound Healing J. Virol., July 1, 2008; 82(13): 6524 - 6535. [Abstract] [Full Text] [PDF]

				D. M. Richards, S. L. Dalheimer, B. D. Ehst, T. L. Vanasek, M. K. Jenkins, M. I. Hertz, and D. L. Mueller Indirect Minor Histocompatibility Antigen Presentation by Allograft Recipient Cells in the Draining Lymph Node Leads to the Activation and Clonal Expansion of CD4+ T Cells That Cause Obliterative Airways Disease J. Immunol., March 15, 2004; 172(6): 3469 - 3479. [Abstract] [Full Text] [PDF]

				F.-U. Sack, T. J. Vielfort, A. Koch, M. Haass, S. Taylor, H. F. Otto, S. Hagl, and P. A. Schnabel The role of platelet derived growth factor in endomyocardial biopsies shortly after heart transplantation in relation to postoperative course Eur. J. Cardiothorac. Surg., January 1, 2004; 25(1): 91 - 97. [Abstract] [Full Text] [PDF]

				F. De Marchis, D. Ribatti, C. Giampietri, A. Lentini, D. Faraone, M. Scoccianti, M. C. Capogrossi, and A. Facchiano Platelet-derived growth factor inhibits basic fibroblast growth factor angiogenic properties in vitro and in vivo through its alpha receptor Blood, March 15, 2002; 99(6): 2045 - 2053. [Abstract] [Full Text] [PDF]

				R. K. Sihvola, V. P. Pulkkinen, P. K. Koskinen, and K. B. Lemstrom Crosstalk of endothelin-1 and platelet-derived growth factor in cardiac allograft arteriosclerosis J. Am. Coll. Cardiol., February 20, 2002; 39(4): 710 - 717. [Abstract] [Full Text] [PDF]

				D. J. Lamb, T. Y. Avades, and G. A. A. Ferns Endogenous Neutralizing Antibodies Against Platelet-Derived Growth Factor-AA Inhibit Atherogenesis in the Cholesterol-Fed Rabbit Arterioscler. Thromb. Vasc. Biol., June 1, 2001; 21(6): 997 - 1003. [Abstract] [Full Text] [PDF]

				E. A. KALLIO, K. B. LEMSTRÖM, P. J. HÄYRY, U. S. RYAN, and P. K. KOSKINEN Blockade of Complement Inhibits Obliterative Bronchiolitis in Rat Tracheal Allografts Am. J. Respir. Crit. Care Med., April 1, 2000; 161(4): 1332 - 1339. [Abstract] [Full Text]

				E. A. KALLIO, P. K. KOSKINEN, E. AAVIK, E. BUCHDUNGER, and K. B. LEMSTRÖM Role of Platelet-derived Growth Factor in Obliterative Bronchiolitis (Chronic Rejection) in the Rat Am. J. Respir. Crit. Care Med., October 1, 1999; 160(4): 1324 - 1332. [Abstract] [Full Text]

				L. M. Khachigian, F. S. Santiago, L. A. Rafty, O. L.-W. Chan, G. J. Delbridge, A. Bobik, T. Collins, and A. C. Johnson GC Factor 2 Represses Platelet-Derived Growth Factor A-Chain Gene Transcription and Is Itself Induced by Arterial Injury Circ. Res., June 11, 1999; 84(11): 1258 - 1267. [Abstract] [Full Text] [PDF]

				S. Makela, H. Savolainen, E. Aavik, M. Myllarniemi, L. Strauss, E. Taskinen, J.-A. Gustafsson, and P. Hayry Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors alpha  and beta PNAS, June 8, 1999; 96(12): 7077 - 7082. [Abstract] [Full Text] [PDF]

				R. Sihvola, P. Koskinen, M. Myllarniemi, M. Loubtchenkov, P. Hayry, E. Buchdunger, and K. Lemstrom Prevention of Cardiac Allograft Arteriosclerosis by Protein Tyrosine Kinase Inhibitor Selective for Platelet-Derived Growth Factor Receptor Circulation, May 4, 1999; 99(17): 2295 - 2301. [Abstract] [Full Text] [PDF]

				S. KHARE, U. KUMAR, R. SASI, L. PUEBLA, L. CALDERON, K. LEMSTROM, P. HAYRY, and A. Y. C. PATEL Differential regulation of somatostatin receptor types 1-5 in rat aorta after angioplasty FASEB J, February 1, 1999; 13(2): 387 - 394. [Abstract] [Full Text]

				H. Lou, M. B. Martin, A. Stoica, P. W. Ramwell, and M. L. Foegh Upregulation of Estrogen Receptor-{alpha} Expression in Rabbit Cardiac Allograft Circ. Res., November 2, 1998; 83(9): 947 - 951. [Abstract] [Full Text] [PDF]